Warning: Undefined variable $insensitive in /home/u224081662/domains/popularscientist.com/public_html/wp-content/plugins/internal-link-building-plugin/internal_link_building.php on line 201

Warning: Undefined variable $insensitive in /home/u224081662/domains/popularscientist.com/public_html/wp-content/plugins/internal-link-building-plugin/internal_link_building.php on line 202

Dr. Santosh Kumar Prajapati | Alzheimer Disease | Best Researcher AwardūüŹÜ

University of South Florida United States

Author Profile

Early Academic Pursuits

Santosh Kumar Prajapati embarked on his academic journey with a Bachelor's in Pharmacy from L.N.C.T Bhopal, R.G.P.V, where he demonstrated early promise with a commendable score of 72.27%. He further honed his skills through a Master's in Pharmacology from the prestigious Department of Pharmaceutical Engineering at IIT-(BHU), where he achieved a notable CGPA of 8.2. His academic prowess continued to shine as he pursued a Ph.D. in Pharmacology from the same department, where his exceptional dedication and scholarly acumen earned him a remarkable CGPA of 9.5.

Professional Endeavors

His professional journey is marked by a diverse range of experiences, reflecting his multidisciplinary approach to pharmacology. He began his career as a Research Fellow at the Center of Excellence for Aging and Brain Repair at USF-Health, where he delved into cutting-edge research on neurodegenerative diseases. This paved the way for his involvement in several industrial projects, including the pharmacological evaluation of anti-Alzheimer's, anti-diabetic, and anti-aging effects of natural drugs in experimental settings within the United States.

Contributions and Research Focus

His research focus underscores his commitment to unraveling the complexities of neurodegenerative disorders and related therapeutic interventions. His current research endeavors span a spectrum of critical areas, from investigating the role of gut microbiota in Alzheimer's disease to exploring the neurotherapeutic potential of various pharmacological agents in mitigating conditions like Parkinson's disease and PTSD. Notably, his contributions extend to the development of innovative models for drug screening and elucidating the intricate interplay between mitochondrial dynamics and cognitive decline.

Accolades and Recognition

His contributions to the field of pharmacology have been widely recognized through numerous accolades and awards. Noteworthy among these is his receipt of the National Science Foundation Research and Innovation Grant at the University of South Florida, a testament to the caliber of his research endeavors. Additionally, his exemplary performance in the Graduate Pharmacy Aptitude Test (GPAT) earned him a prestigious scholarship from the Ministry of Human Resource Development (MHRD), Government of India.

Impact and Influence

His scholarly impact is evident through his prolific publication record, which encompasses a wide array of peer-reviewed articles in esteemed journals such as Ageing Research Reviews, Journal of Affective Disorders, and Neuroscience and Behavioral Physiology. His research findings have contributed significantly to advancing our understanding of neurodegenerative disorders and have the potential to inform future therapeutic strategies.

Legacy and Future Contributions

As He continues to tread the path of academic and scientific excellence, his legacy is poised to endure through his groundbreaking research, mentorship of aspiring scholars, and continued pursuit of innovative solutions to pressing healthcare challenges. With an unwavering dedication to pushing the boundaries of pharmacological research, he remains steadfast in his commitment to making meaningful contributions to the field and shaping the future of healthcare.


A total of  339 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations¬† ¬† ¬† ¬† ¬† ¬† 339
  • h-index¬† ¬† ¬† ¬† ¬† ¬† ¬† 11
  • i10-index¬† ¬† ¬† ¬† ¬† ¬†11

Notable Publications 

Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease

Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1, 3, 4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease

Coenzyme Q10 prevents mitochondrial dysfunction and facilitates pharmacological activity of atorvastatin in 6-OHDA induced dopaminergic toxicity in rats

Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer’s action: Design, synthesis, crystal …

Neuro-nutraceutical potential of Asparagus racemosus: A review

Centella asiatica prevents D-galactose-Induced cognitive deficits, oxidative stress and neurodegeneration in the adult rat brain

Repeated caffeine administration aggravates post-traumatic stress disorder-like symptoms in rats

Non-selective orexin-receptor antagonist attenuates stress-re-stress-induced core PTSD-like symptoms in rats: Behavioural and neurochemical analyses

Supplementation of taurine improves ionic homeostasis and mitochondrial function in the rats exhibiting post-traumatic stress disorder-like symptoms

Development and treatment of cognitive inflexibility in sub-chronic stress‚Äďre-stress (SRS) model of PTSD

A novel stress re-stress model: Modification of restressor cue induces long-lasting post-traumatic stress disorder-like symptoms in rats

Preclinical and Clinical Report on Target-Based Therapy in Alcohol Use Disorder


Dr.Santosh Kumar Prajapati | Alzheimer Disease | Best Researcher Award

You May Also Like